CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS)

$0 None (None%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 73

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) News Sources

Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit

24-06-2026

yahoo.com

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

08-07-2026

yahoo.com

Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026

20-07-2026

yahoo.com

Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers

21-07-2026

yahoo.com

Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference

27-07-2026

yahoo.com

Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

13-08-2026

yahoo.com

Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

08-09-2026

yahoo.com

Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering

17-09-2026

yahoo.com

Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency

25-09-2026

yahoo.com

Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026

19-10-2026

yahoo.com

CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) Sentiment Trend

0 25 50 75 100 84 60 75 85 87 89 75 82 16 79 24-06-2026 08-07-2026 20-07-2026 21-07-2026 27-07-2026 13-08-2026 08-09-2026 17-09-2026 25-09-2026 19-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) FAQs

toggle

What is the current price of CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS)?

The current price of CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) is $0.


toggle

CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) absolute price change since previous trading day?

The absolute price change of CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) since the previous trading day is $None.


toggle

CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) percentage price change since previous trading day?

The percentage price change of CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) since the previous trading day is None%.


toggle

What is the most recent average sentiment score for CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS)?

The most recent average sentiment score for CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) is 73 out of 100.


toggle

What is the most recent average sentiment for CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS)?

The most recent sentiment for CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) is .


SEC-8K** Filing Available For CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.